Sandu Pharmaceuticals Limited (BOM:524703)
India flag India · Delayed Price · Currency is INR
44.13
-0.01 (-0.02%)
At close: May 27, 2026

Sandu Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
426295473554593620
Market Cap Growth
-12.48%-37.70%-14.64%-6.51%-4.32%144.92%
Enterprise Value
362262445512532582
Last Close Price
44.1330.5248.1955.7550.2066.93
PE Ratio
24.1116.7030.5037.9439.0139.00
PS Ratio
0.610.420.700.820.910.95
PB Ratio
0.980.681.131.371.511.70
P/TBV Ratio
0.980.681.131.371.511.70
P/FCF Ratio
7.905.464550.88--575.52
P/OCF Ratio
6.974.8249.9072.96268.2465.33
EV/Sales Ratio
0.520.380.660.760.810.89
EV/EBITDA Ratio
12.078.7417.5224.0322.9021.61
EV/EBIT Ratio
15.5811.2821.2529.9027.0224.85
EV/FCF Ratio
6.714.864279.97--540.75
Debt / Equity Ratio
0.010.010.010.00--
Debt / EBITDA Ratio
0.140.140.170.03--
Debt / FCF Ratio
0.080.0845.91---
Net Debt / Equity Ratio
-0.15-0.15-0.05-0.03-0.06-0.11
Net Debt / EBITDA Ratio
-2.14-2.14-0.86-0.54-0.99-1.55
Net Debt / FCF Ratio
-1.19-1.19-209.181.722.71-38.73
Asset Turnover
1.251.251.241.261.261.36
Inventory Turnover
2.572.572.592.612.603.38
Quick Ratio
1.181.180.620.580.530.72
Current Ratio
2.432.432.182.101.841.99
Return on Equity (ROE)
4.12%4.12%3.76%3.66%4.02%4.54%
Return on Assets (ROA)
2.60%2.60%2.42%2.01%2.38%3.04%
Return on Invested Capital (ROIC)
4.06%4.01%3.80%3.16%3.90%5.94%
Return on Capital Employed (ROCE)
5.10%5.10%4.80%4.10%4.90%6.30%
Earnings Yield
4.14%5.99%3.28%2.63%2.56%2.56%
FCF Yield
12.66%18.30%0.02%-1.20%-1.43%0.17%
Dividend Yield
2.27%3.28%1.66%1.44%1.49%1.12%
Payout Ratio
43.76%43.76%49.81%49.59%43.46%19.94%
Buyback Yield / Dilution
0.10%0.10%--2.42%-10.93%-20.08%
Total Shareholder Return
2.61%3.38%1.66%-0.98%-9.44%-18.96%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.